Bone Morphogenetic Proteins (BMPs) are a group of signaling molecules that play pivotal roles in bone and tissue development. Belonging to the transforming growth factor-beta (TGF-β) superfamily, BMPs are involved in various cellular processes, including differentiation, proliferation, and apoptosis. BMPs were initially discovered for their ability to induce the formation of bone and cartilage. They are crucial for skeletal development during embryogenesis and continue to influence bone remodeling and repair throughout life. BMPs act as morphogens, regulating the patterning and differentiation of cells in a concentration-dependent manner. In addition to their skeletal functions, BMPs are involved in organogenesis, tissue repair, and homeostasis. They exert their effects by binding to cell surface receptors and activating intracellular signaling cascades, particularly the Smad pathway. The therapeutic potential of BMPs has led to their use in medical applications, such as bone grafting and spinal fusion procedures. However, the complex regulatory network of BMP signaling requires careful consideration to avoid unintended consequences, including excessive bone formation or tumorigenesis. Understanding the multifaceted roles of BMPs in development and disease is a subject of ongoing research. Manipulating BMP signaling holds promise for advancing regenerative medicine, tissue engineering, and treatments for conditions related to bone and tissue disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States